These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 22387538)

  • 21. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
    Pagnan G; Di Paolo D; Carosio R; Pastorino F; Marimpietri D; Brignole C; Pezzolo A; Loi M; Galietta LJ; Piccardi F; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M
    Clin Cancer Res; 2009 Feb; 15(4):1199-209. PubMed ID: 19228726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CopA3 peptide from Copris tripartitus induces apoptosis in human leukemia cells via a caspase-independent pathway.
    Kang BR; Kim H; Nam SH; Yun EY; Kim SR; Ahn MY; Chang JS; Hwang JS
    BMB Rep; 2012 Feb; 45(2):85-90. PubMed ID: 22360885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells.
    Artus C; Maquarre E; Moubarak RS; Delettre C; Jasmin C; Susin SA; Robert-Lézénès J
    Oncogene; 2006 Sep; 25(42):5741-51. PubMed ID: 16636662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenretinide and its relation to cancer.
    Ulukaya E; Wood EJ
    Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptosis-inducing factor plays a critical role in caspase-independent, pyknotic cell death in hydrogen peroxide-exposed cells.
    Son YO; Jang YS; Heo JS; Chung WT; Choi KC; Lee JC
    Apoptosis; 2009 Jun; 14(6):796-808. PubMed ID: 19418225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathway of apoptosis induced in Jurkat T lymphoblasts by anti-HLA class I antibodies.
    Daniel D; Opelz G; Mulder A; Kleist C; Süsal C
    Hum Immunol; 2004 Mar; 65(3):189-99. PubMed ID: 15041157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine.
    Chow KU; Boehrer S; Geduldig K; Krapohl A; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2001 May; 86(5):485-93. PubMed ID: 11410411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
    Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis.
    Morales JC; Ruiz-Magaña MJ; Carranza D; Ortiz-Ferrón G; Ruiz-Ruiz C
    Cancer Lett; 2010 Nov; 297(1):91-100. PubMed ID: 20580868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The roles of AIF and Endo G in the apoptotic effects of benzyl isothiocyanate on DU 145 human prostate cancer cells via the mitochondrial signaling pathway.
    Liu KC; Huang YT; Wu PP; Ji BC; Yang JS; Yang JL; Chiu TH; Chueh FS; Chung JG
    Int J Oncol; 2011 Mar; 38(3):787-96. PubMed ID: 21206973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of death receptor and mitochondrial pathways in conventional chemotherapy drug induction of apoptosis.
    Wang P; Song JH; Song DK; Zhang J; Hao C
    Cell Signal; 2006 Sep; 18(9):1528-35. PubMed ID: 16442262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes.
    Weis M; Schlegel J; Kass GE; Holmström TH; Peters I; Eriksson J; Orrenius S; Chow SC
    Exp Cell Res; 1995 Aug; 219(2):699-708. PubMed ID: 7543858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-(4-Methylphenyl)-1,3-selenazol-4-one induces apoptosis by different mechanisms in SKOV3 and HL 60 cells.
    Ahn HJ; Koketsu M; Yang EM; Kim YM; Ishihara H; Yang HO
    J Cell Biochem; 2006 Oct; 99(3):807-15. PubMed ID: 16676363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro.
    Cevatemre B; Ari F; Sarimahmut M; Oral AY; Dere E; Kacar O; Adiguzel Z; Acilan C; Ulukaya E
    Anticancer Drugs; 2013 Jul; 24(6):577-86. PubMed ID: 23542749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-(4-hydroxyphenyl)retinamide-induced death in human lymphoblastoid cells: 50 kb DNA breakage as a means of distinguishing apoptosis from necrosis.
    Springer LN; Stewart BW
    Cancer Lett; 1998 Jun; 128(2):189-96. PubMed ID: 9683282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified STAP conditions facilitate bivalent fate decision between pluripotency and apoptosis in Jurkat T-lymphocytes.
    Kim JY; Cheng X; Alborzinia H; Wölfl S
    Biochem Biophys Res Commun; 2016 Apr; 472(4):585-91. PubMed ID: 26972255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THP-1 leukemia cancer treatment using a portable plasma device.
    Thiyagarajan M; Waldbeser L; Whitmill A
    Stud Health Technol Inform; 2012; 173():515-7. PubMed ID: 22357047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.